CZ2001962A3 - Nový prostředek - Google Patents

Nový prostředek Download PDF

Info

Publication number
CZ2001962A3
CZ2001962A3 CZ2001962A CZ2001962A CZ2001962A3 CZ 2001962 A3 CZ2001962 A3 CZ 2001962A3 CZ 2001962 A CZ2001962 A CZ 2001962A CZ 2001962 A CZ2001962 A CZ 2001962A CZ 2001962 A3 CZ2001962 A3 CZ 2001962A3
Authority
CZ
Czechia
Prior art keywords
component
disorders
treatment
composition according
composition
Prior art date
Application number
CZ2001962A
Other languages
Czech (cs)
English (en)
Inventor
John Evenden
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CZ2001962A3 publication Critical patent/CZ2001962A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ2001962A 1998-09-16 1999-09-13 Nový prostředek CZ2001962A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803157A SE9803157D0 (sv) 1998-09-16 1998-09-16 A new composition

Publications (1)

Publication Number Publication Date
CZ2001962A3 true CZ2001962A3 (cs) 2001-08-15

Family

ID=20412628

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ2001962A CZ2001962A3 (cs) 1998-09-16 1999-09-13 Nový prostředek

Country Status (21)

Country Link
EP (1) EP1121119A1 (ko)
JP (1) JP2002524509A (ko)
KR (1) KR20010099648A (ko)
CN (1) CN1317963A (ko)
AR (1) AR023657A1 (ko)
AU (1) AU6378199A (ko)
BR (1) BR9913765A (ko)
CA (1) CA2342585A1 (ko)
CZ (1) CZ2001962A3 (ko)
EE (1) EE200100156A (ko)
HU (1) HUP0103569A3 (ko)
ID (1) ID28359A (ko)
IL (1) IL141520A0 (ko)
IS (1) IS5877A (ko)
NO (1) NO20011313L (ko)
PL (1) PL346769A1 (ko)
SE (1) SE9803157D0 (ko)
SK (1) SK3272001A3 (ko)
TR (1) TR200100769T2 (ko)
WO (1) WO2000015219A1 (ko)
ZA (1) ZA200101951B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
DE60122015T2 (de) 2000-10-13 2006-11-23 Neurosearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
WO2006123243A2 (en) 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
KR20010099648A (ko) 2001-11-09
TR200100769T2 (tr) 2001-11-21
EE200100156A (et) 2002-08-15
HUP0103569A3 (en) 2002-03-28
SE9803157D0 (sv) 1998-09-16
PL346769A1 (en) 2002-02-25
IS5877A (is) 2001-03-05
CN1317963A (zh) 2001-10-17
AU6378199A (en) 2000-04-03
JP2002524509A (ja) 2002-08-06
ZA200101951B (en) 2002-06-10
NO20011313L (no) 2001-05-16
NO20011313D0 (no) 2001-03-15
ID28359A (id) 2001-05-17
HUP0103569A2 (hu) 2002-02-28
BR9913765A (pt) 2001-06-05
CA2342585A1 (en) 2000-03-23
AR023657A1 (es) 2002-09-04
IL141520A0 (en) 2002-03-10
WO2000015219A1 (en) 2000-03-23
EP1121119A1 (en) 2001-08-08
SK3272001A3 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
US6184218B1 (en) Composition and methods employing it for the treatment of 5-HT-mediated disorders
CA2383785C (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
MX2007013064A (es) Metodo para modular la funcion de la vejiga.
BRPI0713733A2 (pt) métodos para diminuir os sintomas de depressão e para tratar uma ou mais condições psicológicas, composição farmacêutica e kit
JP2002511414A (ja) 神経疾患のための新しい治療
US6472423B1 (en) Pharmaceutical composition
CZ2001962A3 (cs) Nový prostředek
CZ2001961A3 (cs) Nový prostředek
AU6378299A (en) A new composition
JP2002524507A (ja) 新規組成物
MXPA01002543A (en) A new composition
CA2338326A1 (en) Use of moclobemide and metabolites for treating and preventing substance abuse
JP2015520154A (ja) （１ｒ，４ｒ）−６’−フルオロ−Ｎ，Ｎ−ジメチル−４−フェニル−４’，９’−ジヒドロ−３’Ｈ−スピロ［シクロヘキサン−１，１’−ピラノ［３，４，ｂ］インドール］−４−アミンおよび抗うつ薬を含む医薬組成物
MXPA01002370A (en) A new composition
MX2008012212A (es) Metodos para tratar trastornos cognitivos y otros afines.